Petros Pharmaceuticals, Inc. (PTPI) Income Annual - Discounting Cash Flows
Petros Pharmaceuticals, Inc.
PTPI (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
Report Filing 2025-05-15 2025-03-31 2024-05-31 2023-03-31 2022-03-31 2021-03-31 2019-12-31 2018-12-31
Revenue 3.72 5.11 5.82 5.99 7.81 9.56 15.58 14.05
Cost of Revenue 0.881 1.21 1.63 2.29 1.6 4.05 7.43 10.48
Gross Profit 2.84 3.9 4.19 3.7 6.21 5.51 8.15 3.57
Operating Expenses 18.05 21.58 17.81 19.55 24.26 22.8 25.02 11.22
Research & Development 1.06 2.62 2.41 1.74 1.79 0.46 0 0
Selling, General and Administrative 7.5 8.75 9.26 12.21 15.59 15.67 19.73 11.22
Other Operating Expenses 9.5 10.21 6.14 5.6 6.88 6.66 5.29 0
Operating Income -15.21 -17.68 -13.62 -15.85 -18.05 -17.28 -16.87 -7.65
Net Non-Operating Interest -0.173 -0.189 -0.021 -0.582 0 0 0 11.86
Interest Income 0.268 0.372 0.515 0.014 0.369 3.05 13.84 11.86
Interest Expense 0.441 0.561 0.536 0.596 0.369 3.05 13.84 0
Equity & Other Income/(Expense) 2.03 3.55 5.48 -3.61 9.06 -4.73 -16.29 -36.69
Income Before Tax -13.36 -14.32 -8.16 -20.04 -8.99 -22.01 -33.16 -32.49
Income Tax Expense 0 0 0 7 0.369 -1.43 -0.646 -0.013
Income Attributable to Non-Controlling Interest 1.06 0 0 -7 0 0 0 0
Net Income -14.42 -14.32 -8.16 -20.04 -9.36 -20.59 -32.51 -32.47
Depreciation and Amortization 2.15 2.94 3.42 5.72 6.98 6.75 5.32 8.06
EBITDA -13.06 -14.74 -10.2 -10.13 -11.07 -10.53 -11.55 0.415
Earnings Per Share (EPS) -10.4 -0.023 -6.35 -9.68 -8.25 -38.55 -132.2 -324.7
Diluted Earnings Per Share -10.4 -0.023 -6.35 -9.68 -8.25 -38.55 -132.2 -324.7
Weighted Average Shares Outstanding 1.16 8.03 1.29 2.07 1.09 0.534 0.246 0.1
Diluted Weighted Average Shares Outstanding 1.16 8.03 2.18 2.07 1.09 0.534 0.246 0.1
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us